AI Tools in Mental Health Care
Evaluate and apply AI-based tools for psychiatric assessment, monitoring, and risk detection within a clinically appropriate scope of practice.
What this track covers
This track covers how AI is used across mental health care, including conversational agents for therapy support, FDA-cleared digital therapeutics, passive symptom monitoring, and AI-assisted suicide risk and crisis detection. It focuses on understanding what these tools do, their evidence base, and where clinician judgment must remain central.
What you will practice
- Distinguish FDA-cleared digital therapeutics from unregulated wellness apps
- Interpret AI-generated mood tracking and passive sensing data in a clinical note
- Assess the limitations of AI-based suicide risk prediction tools before acting on output
- Decide when a conversational AI tool is appropriate versus when escalation to a clinician is required
- Identify privacy and therapeutic-relationship risks when introducing AI tools into a treatment plan
Simulator scenario
A patient using a mental health chatbot app reports worsening mood between visits, and the clinician must decide how to weigh the app's flagged risk alert against their own assessment.
Board question topics
- Regulatory status of digital therapeutics in psychiatry
- Appropriate use of AI risk-prediction output in clinical decisions
- Limitations of NLP-based sentiment analysis in patient communication
- Privacy considerations when integrating AI monitoring tools into care
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free